NCT03902496View on ClinicalTrials.gov

Optical Treatment of Migraines Using the Avulux™ Optical Filter in the Form of Spectacle Lenses.

NACompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

March 18, 2019

Primary Completion Date

May 17, 2019

Study Completion Date

May 17, 2019

Conditions
Migraine
Interventions
OTHER

HIT-6 Questionnaire

Headache Impact Test

DEVICE

Avulux Spectacles

Avulux™ Optical Filter in the Form of Spectacle Lenses

DEVICE

Sham Spectacles

Sham

Trial Locations (1)

43215

Remington-Davis Clinical Research, Columbus

All Listed Sponsors
lead

Avulux, Inc.

INDUSTRY

NCT03902496 - Optical Treatment of Migraines Using the Avulux™ Optical Filter in the Form of Spectacle Lenses. | Biotech Hunter | Biotech Hunter